An interventional study of JASPER™ Robotic Surgical System in Cataract, sponsored by ForSight Robotics Ltd. Recruiting at 1 site in Philippines. Open to participants aged 55 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-07-24.
Sponsored by ForSight Robotics Ltd · Not applicable, Interventional, and Treatment
This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery.
1,629 studies on the registry are indexed under Cataract; 235 are open to participants now.
This study's planned enrollment of 40 is below the median of 79 across 1,092 interventional studies indexed under Cataract.
Browse Cataract studies →This is the only study on the registry with ForSight Robotics Ltd as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Main Inclusion Criteria:
Main Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects will undergo cataract surgery using the JASPER™ Robotic Surgical System.
Device: JASPER™ Robotic Surgical System
The JASPER™ Robotic Surgical System is a robotically assisted surgical system intended to assist ophthalmic surgeons in performing cataract surgery.
Successful completion of planned Robotic-Assisted cataract surgery
Proportion of study eyes in which the planned robotic cataract surgery is completed using the JASPER™ Robotic Surgical System without conversion to manual technique.
Time frame: Intra-operative
Incidence and Type of Adverse Events (AEs) and Serious Adverse Events (SAEs)
Incidence and type of all AEs and SAEs occurring intraoperatively and during the postoperative follow-up period.
Time frame: From surgery through 30 days post-procedure
Distribution of pre and postoperative Best Corrected Visual acuity
Distribution of preoperative and postoperative BCVA
Time frame: Baseline and up to 30 days post-procedure
Postoperative Ophthalmic examination findings
Postoperative slit lamp and dilated fundus examinations findings
Time frame: Up to 30 days post-procedure
Plan to share: No — Individual participant data (IPD) will not be shared at this time due to privacy, confidentiality, and regulatory considerations. Future sharing may be considered under appropriate agreements and conditions.
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.
Of 190 industry-sponsored interventional studies with no phase under Cataract, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 28. This study's planned 12 months is below that.
Counting every sponsor, half of 490 studies reached it within 17 months; a quarter within 9 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.